Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding PAVmed Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of PAVM: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders6461−3
Shares9.70M10.0M+345.3K (+3.6%)
Value$4.62M$3.76M−$863.0K (−18.7%)

New holders (7)

Institutions that held PAVmed Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to PAVM in Q1 2023
InstitutionSharesValue% of portfolio
Ayrton Capital LLC430,317$160.7K0.58%
Integrated Wealth Concepts LLC30,190$11.0K0.00%
McAdam, LLC13,792$5.15K0.00%
Whitcomb & Hess, Inc.11,111$4.15K0.00%
Thompson Investment Management, Inc.50$190.00%
Lumature Wealth Partners, LLC14$50.00%
Royal Bank of Canada382$00.00%

Sold out (10)

Institutions that held PAVmed Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of PAVM in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Alterity Financial Group, LLC67,995$32.6K
Glassman Wealth Services34,779$16.7K
Pacific Wealth Management30,000$14.4K
WealthPlan Investment Management, LLC32,335$13.6K
Citadel Advisors LLC25,144$12.1K
Merit Financial Group, LLC16,400$7.87K
Barclays PLC8,000$3.84K
Rockefeller Capital Management L.P.2,500$1.00K
The PNC Financial Services Group, Inc.2,000$960
BNP Paribas Arbitrage, SA102$49